General Information
Version
1.0
Revision date
2018-12-07
Product name
Cefotaxime, Sodium Salt
CAS No.
64485-93-4
REACH No
is
1.2.1 Relevant identified uses
Reagent for development and research For additional information on uses please refer to the Merck
Emergency telephone
+61 (3) 8727 6300, +64 4 917 9888
Icons in SDS
Company Information
company name
Merck KGaA
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor. Reduced labelling (≤125 ml)
Precautionary statements
P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor. CAS-No. 64485-93-4
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Respiratory sensitisation, Category 1, H334 Skin sensitisation, Category 1, H317 For the full text of the H-Statements mentioned in this Section, see Section 16.
